1. Home
  2. FGEN vs BOWN Comparison

FGEN vs BOWN Comparison

Compare FGEN & BOWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGEN
  • BOWN
  • Stock Information
  • Founded
  • FGEN 1993
  • BOWN 2023
  • Country
  • FGEN United States
  • BOWN United States
  • Employees
  • FGEN N/A
  • BOWN N/A
  • Industry
  • FGEN Biotechnology: Pharmaceutical Preparations
  • BOWN
  • Sector
  • FGEN Health Care
  • BOWN
  • Exchange
  • FGEN Nasdaq
  • BOWN Nasdaq
  • Market Cap
  • FGEN 33.5M
  • BOWN 28.5M
  • IPO Year
  • FGEN 2014
  • BOWN 2023
  • Fundamental
  • Price
  • FGEN $7.09
  • BOWN N/A
  • Analyst Decision
  • FGEN Strong Buy
  • BOWN
  • Analyst Count
  • FGEN 1
  • BOWN 0
  • Target Price
  • FGEN $250.00
  • BOWN N/A
  • AVG Volume (30 Days)
  • FGEN 74.7K
  • BOWN 2.6K
  • Earning Date
  • FGEN 08-05-2025
  • BOWN 01-01-0001
  • Dividend Yield
  • FGEN N/A
  • BOWN N/A
  • EPS Growth
  • FGEN N/A
  • BOWN N/A
  • EPS
  • FGEN N/A
  • BOWN 0.02
  • Revenue
  • FGEN $6,996,000.00
  • BOWN N/A
  • Revenue This Year
  • FGEN N/A
  • BOWN N/A
  • Revenue Next Year
  • FGEN N/A
  • BOWN N/A
  • P/E Ratio
  • FGEN N/A
  • BOWN $206.51
  • Revenue Growth
  • FGEN N/A
  • BOWN N/A
  • 52 Week Low
  • FGEN $4.50
  • BOWN $2.71
  • 52 Week High
  • FGEN $38.25
  • BOWN $19.77
  • Technical
  • Relative Strength Index (RSI)
  • FGEN 60.54
  • BOWN 49.69
  • Support Level
  • FGEN $5.37
  • BOWN $8.70
  • Resistance Level
  • FGEN $5.73
  • BOWN $10.20
  • Average True Range (ATR)
  • FGEN 0.49
  • BOWN 0.42
  • MACD
  • FGEN 0.27
  • BOWN 0.04
  • Stochastic Oscillator
  • FGEN 83.80
  • BOWN 79.04

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.

About BOWN Bowen Acquisition Corp

Bowen Acquisition Corp is a blank check company.

Share on Social Networks: